Koyfin Home > Directory > Health Care > Acceleron Pharma > Market Cap

Acceleron Pharma Market Cap Chart (XLRN)

Acceleron Pharma annual/quarterly Market Cap from 2013 to 2020. Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
  • Acceleron Pharma Market Cap for the quarter ending October 10, 2020 was $6,264m a -3.70% decrease of -232m year over year
  • Acceleron Pharma Market Cap for the last 12 months ending October 10, 2020 was $6,264m a -3.70% decrease of -232m year over year
  • Acceleron Pharma Annual Market Cap for 2020 was $6,264m a -2.21% decrease of -138m from 2019
  • Acceleron Pharma Annual Market Cap for 2020 was $6,402m a 0.67% increase of 43m from 2019
  • Acceleron Pharma Annual Market Cap for 2020 was $6,359m a -2.15% decrease of -137m from 2019
Other Valuation Metrics:
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN Market Cap Data

10/2020$6,264m
10/2020$6,402m
10/2020$6,359m
10/2020$6,496m
10/2020$6,493m
10/2020$6,549m
10/2020$6,552m
10/2020$6,393m
10/2020$6,713m
10/2020$6,901m

Annual XLRN Market Cap Data

2020$6,264m
2020$6,402m
2020$6,359m
2020$6,496m
2020$6,493m
2020$6,549m
2020$6,552m
2020$6,393m
2020$6,713m
2020$6,901m